Journals / Eurasian Journal of Medicine / 2022 / Cilt: 54 - Sayı: 2

High Fetuin-A Levels in Children with Celiac Disease

Pages
186–190
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Increased Fetuin-A levels and positive correlation between Fetuin-A and bone mineral density in children with celiac disease suggest that Fetuin-A may be a biomarker for celiac disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Fetuin-A is a multifunctional non-collagen protein that plays a role in bone mineralization.
📊
Key Findings & Data:Materials and Methods: The study was conducted on 59 children with celiac and 29 healthy children.
💡
Conclusion & Impact:Conclusion: Increased Fetuin-A levels and positive correlation between Fetuin-A and bone mineral density in children with celiac disease suggest that Fetuin-A may be a biomarker for celiac disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Fetuin-A is a multifunctional non-collagen protein that plays a role in bone mineralization. Celiac disease is a chronic inflammatory disorder of the small intestine due to exposure to gluten. In this research, it was aimed to investigate levels of Fetuin-A and its relationship with bone mineral density in children with celiac disease. Materials and Methods: The study was conducted on 59 children with celiac and 29 healthy children. The celiac disease group was composed of three groups, newly diagnosed, gluten-free diet compliant and, non- glutenfree diet compliant patients. Serum Fetuin-A concentrations were measured by an enzyme-linked immunosorbent assay kit. Measurement of bone mineral density was performed a dual-energy x-ray absorptiometry. Results: Serum Fetuin-A levels were 136.85 ± 38.09 μg/L and 112.95 ± 44.39 μg/L in the celiac disease and healthy control groups, respectively. There was a statistically significant difference between groups in levels of serum Fetuin-A (P < .05). A significant positive correlation was observed between serum Fetuin-A and bone mineral density Z-score in the celiac patients. Conclusion: Increased Fetuin-A levels and positive correlation between Fetuin-A and bone mineral density in children with celiac disease suggest that Fetuin-A may be a biomarker for celiac disease.

🔖

Cite This Article

GÜL, M. A., VOLKAN, B., KURT, N., ÖZGERİŞ, F. B., ÇAYIR, A. (2022). High Fetuin-A Levels in Children with Celiac Disease. Eurasian Journal of Medicine, Cilt: 54 - Sayı: 2, 186–190. https://ajindex.com/articles/508774

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Tack GJ, Verbeek WH, Schreurs MW, Mulder CJ. The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol. 2010
  2. 7(4):204-213. [CrossRef] 2. Newton KP, Singer SA. Celiac disease in children and adolescents: special considerations. Semin Immunopathol. 2012
  3. 34(4):479-496. [CrossRef] 3. Phan CM, Guglielmi G. Metabolic bone disease in patients with malabsorption. Semin Musculoskelet Radiol. 2016
  4. 20(4):369-375. [CrossRef] 4. Kemppainen T, Kröger H, Janatuinen E, et al. Osteoporosis in adult patients with celiac disease. Bone. 1999
  5. 24(3):249-255. [CrossRef] 5. Sdepanian VL, de Miranda Carvalho CN, de Morais MB, Colugnati FA, Fagundes-Neto U. Bone mineral density of the lumbar spine in children and adolescents with celiac disease on gluten-free diet in Sao Paulo, Brasil. J Pediatr Gastroenterol Nutr. 2003
  6. 37(5):571-576. [CrossRef] 6. Volkan B, Fettah A, İşlek A, Kara SS, Kurt N, Çayır A. Bone mineral density and vitamin K status in children with celiac disease: is there a relation? Turk J Gastroenterol. 2018
  7. 29(2):215-220. [CrossRef] 7. Mori K, Emoto M, Inaba M. Fetuin-A: a multifunctional protein. Recent Pat Endocr Metab Immune Drug Discov. 2011
  8. 5(2):124-146. [CrossRef] 8. Termine JD, Belcourt AB, Conn KM, Kleinman HK. Mineral and collagen-binding proteins of fetal calf bone. J Biol Chem. 1981
  9. 256(20):10403- 10408. [CrossRef] 9. Wendel M, Heinegård D, Franzén A. A major non-collagenous 62 kDa protein from rat bone mineralized matrix is identical to pp63 a phosphorylated glycoprotein from liver. Matrix. 1993
  10. 13(4):331-339. [CrossRef] 10. Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/ fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 2003
  11. 112(3):357- 366. [CrossRef] 11. Westenfeld R, Schäfer C, Smeets R, et al. Fetuin- A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant. 2007
  12. 22(6):1537- 1546. [CrossRef] 12. Westenfeld R, Schäfer C, Krüger T, et al. Fetuin- A protects against atherosclerotic calcification in CKD. J Am Soc Nephrol. 2009
  13. 20(6):1264-1274. [CrossRef] 13. Schinke T, Amendt C, Trindl A, Pöschke O, Müller-Esterl W, Jahnen-Dechent W. The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem. 1996
  14. 271(34):20789-20796. [CrossRef]